Leadership: Page 25

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Reputation Matrix

    The pharmaceutical industry is in some respects the victim of its own success. In fact, some public relations experts believe that the industry suffers from cognitive dissonance. “Many people are not comfortable viewing an industry responsible for developing innovative medicines as being a profit...

    By Denise Myshko • Sept. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Publication Planning Update

    Title VIII of FDAAA, which requires the posting of ­clinical trial data within one year from last patient last visit, puts the squeeze on ­ publication ­planners to get study results published in a very tight time frame. The Title VIII section of the Food and Drug Administration Amendments Act (F...

    By Robin Robinson • Sept. 28, 2009
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List by Section

    The Commanders & Chiefs 12 Ahsan Awan Ross Bjella Laurie Cooke, R.Ph. John Farinacci Tuan Ha-Ngoc Fred Hassan Thomas Hughes, Ph.D. Greg Johnson Rick Keefer Kyle Kennedy William Maichle John Maraganore, Ph.D. Francois Nader, M.D. Nader Naeymi-Rad Angus Russell Laurent Schockmel, DVM Jeffrey St...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Reading List

    NON-FICTION Memo to the President: How We Can Restore America’s Reputation and Leadership • Madeleine Albright Making it all Work: Winning at the Game of Work and the Business of Life • David Allen Who Goes First?: The Story of Self-Experimentation in Medicine • Lawrence K. Altman It’s Not About ...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Predicting the Future The Business Case for Forecasting

    By Kim Ribbink Risk is an inherent part of the pharmaceutical business — risk of failure in clinical trials, risk that a product won’t achieve regulatory approval, risk that a product underperforms in the market, and risk of withdrawal after adverse reactions and the costly lawsuits that can foll...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ePocrates To Collaborate With Express Scripts on HANDHELD FORMULARY INITIATIVE ePocrates has agreed to incorporate the formu lary information of Express Scripts Inc., a national pharmacy benefits manager, into the ePocrates Rx Form...

    By PharmaVoice Team • March 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    The hottest concept in pharmaceutical marketing and PR today — for that matter the hottest concept in all marketing today — is so old that it didn’t seem at all out of place when it turned up in a lyric in the biblical rock opera, Jesus Christ Superstar: “What’s the Buzz, tell us what’s a happeni...

    By Robert Chandler and Gianfranco Chicco • March 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    America’s pharmaceutical industry is helping the process of healing the nation in the wake of September 11th. Within hours of the terrorist attacks on New York and Washington, America’s pharmaceutical companies responded with medicines and vaccines, supplies for workers and rescuers, and aid for ...

    By Taren Grom • Feb. 17, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HBA Leadership Conference

    1. Chicago served as the host city for the 6th Annual HBA Leadeship Conference. 2. Arlene Kirsh, GlaxoSmithKline, and Leadership Conference Chair and Director of Professional Development, Laurie Cooke, HBA CEO, and Catherine Sohn, GlaxoSmithKline, and Past WOTY, take a moment during star gazing a...

    By PharmaVoice Team • Jan. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Salesforces

    SALES & Marketing Salesforces The Salesforce of the Future: MORE SERVICE, LESS SELL As companies — Sanofi-Aventis, Merck, Wyeth, Schering-Plough, Novartis — continue to make headlines for collectively laying off thousands of sales representatives, the industry looks for innovative ways to do ...

    By PharmaVoice Team • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Pharmaceutical companies as well as their partners are feeling the heat. They are facing unprecedented challenges on a global scale. More so than ever, their business strategies are being put to the test. How well they do will depend on the resilience of their operations and the vision of their l...

    By Taren Grom • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Medicare Incentives Push E-Prescribing to Top of Mind

    2008 VIEW on ESolutions EPRESCRIBING It’s no secret that thousands of private practice physicians throughout the country face a financial crunch. Declining reimbursement rates have produced a profoundly negative impact in several areas of healthcare — particularly in oncology, nephrology and othe...

    By PharmaVoice Team • Oct. 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Cover

    PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF

    By PharmaVoice Team • July 28, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...

    By Taren Grom • July 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Mentors

    Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Growing Community of Good Citizens, Part II

    SPECIAL FEATURE # CITIZENS PHILANTHROPY HAS BECOME PART AND PARCEL OF CORPORATE LIFE IN MANY NATIONS.FOR SOME COMPANIES IN THE LIFESCIENCES, HOWEVER,THERE IS A GROWING DESIRE TO TAKE THAT ONE STEP FURTHERWITH GRASSROOTSVOLUNTEERISM. Last month, PharmaVOICE told its readers about some of the remar...

    By Kim Ribbink • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    It’s that time of year again, what we jokingly refer to as “conference season.” As everyone heads into several months of exhibitions, informative sessions, and symposia with lanyards in tow, we thought it would be a good idea to provide some best practices for getting the most out of your confere...

    By Taren Grom • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The New CME: Live and Electronic

    CME CONTENT, DELIVERY, AND ACCREDITATION Without Commercial Interest BY TAREN GROM The American Medical Association defines continuing medical education (CME) as educational activities that serve to maintain,develop, or increase the knowledge, skills, professional performance,and relationships t...

    By PharmaVoice Team • April 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The PR Connection

    THE PR CONNECTION BY ELISABETH PENA PUBLIC-RELATIONS strategies are essential to helping rebuild the industry’s tarnished image and repair an eroded sense of trust. MARITA GOMEZ … One of the most common misconceptions about PR is that it is just about press releases — PR is much more than that. P...

    By Elisabeth Pena • April 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Regulatory Submissions: Improving the Process

    BY TAREN GROM IMPROVING E-STRATEGIES The inability to effectively manage complex submission documentation for new drug applications (NDAs) and other regulated dossiers is a major factor in slowing the time it takes to bring a product to market. These delays cost the lifescience industry millions ...

    By PharmaVoice Team • April 21, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Alan Holmer — The Industry's Champion

    THE INDUSTRY’S CHAMPION BY KIM RIBBINK After a weighty career in politics and the law, and now seven years into his leadership position at the Pharmaceutical Research and Manufacturers of America, Alan F. Holmer is positioning the organization to address criticisms of the industry and convey to t...

    By PharmaVoice Team • April 21, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    80 J u n e 20 03 PharmaVOICE Pharma POOL Dr. Catherine BONUCCELLI AstraZeneca NamesVP,External Scientific Affairs Catherine Bonuccelli, M.D., has been promoted to the position of VP of external scientific affairs at AstraZeneca, Wilm ington, Del. Dr. Bonuc celli is responsible for building and su...

    By PharmaVoice Team • April 16, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    March 1718 3rd Imaging in Preclinical &Clinical Drug Development San Diego For more information, contact Vivian Frankel, GTCBio, at 6262566405, email [email protected], or visit gtcbio.com. March 1718 The Inaugural U.S.Conference on Comparator Studies Doubletree Hotel,Philadelphia For...

    By PharmaVoice Team • March 2, 2008